GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Net Income Including Noncontrolling Interests

Dabomb Protein Biotech (ROCO:6578) Net Income Including Noncontrolling Interests : NT$6.9 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Dabomb Protein Biotech's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was NT$2.1 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was NT$6.9 Mil.


Dabomb Protein Biotech Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Dabomb Protein Biotech's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Net Income Including Noncontrolling Interests Chart

Dabomb Protein Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.19 -62.45 -44.66 -57.03 11.64

Dabomb Protein Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.85 5.23 -1.51 1.07 2.10

Dabomb Protein Biotech Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$6.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dabomb Protein Biotech Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Dabomb Protein Biotech Business Description

Traded in Other Exchanges
N/A
Address
52,Gungye 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. Its products include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). It operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, China, Vietnam, and Others with majority of the revenue deriving from Vietnam.

Dabomb Protein Biotech Headlines

No Headlines